title: Rush hour traffic: directing T cells to tumor.
authors.affiliation: Department of Lymphoma and Myeloma and Center for Cancer Immunology Research, University of Texas MD Anderson Cancer Center, Houston, TX. sneelapu@mdanderson.org.
authors.forename: Sattva S
authors.initials: SS
authors.lastname: Neelapu
authors.affiliation: Department of Lymphoma and Myeloma and Center for Cancer Immunology Research, University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Larry W
authors.initials: LW
authors.lastname: Kwak
mesh_terms: D019496:Cancer Vaccines / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007371:Interferon-gamma / Q000187:drug effects*; D008213:Lymphocyte Activation / Q000187:drug effects*; D008297:Male; D020360:Neoadjuvant Therapy / Q000379:methods*; D011468:Prostatectomy; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy* / Q000276:immunology*; D013601:T-Lymphocytes / Q000187:drug effects*; D014020:Tissue Extracts / Q000627:therapeutic use*
chemical_list: D019496:Cancer Vaccines; D014020:Tissue Extracts; D007371:Interferon-gamma; C511774:sipuleucel-T